The Valley Desk

ArticleInternational journal of radiation oncology, biology, physicsPublished

Neurocognitive function and quality of life results from a phase II study (NRG/RTOG 0424) of temozolomide-based chemoradiotherapy regimen for high-risk low-grade gliomas

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Thomas Jefferson University. Affiliation source

Publication record

Type
Article
Venue
International journal of radiation oncology, biology, physics
Published
Subject terms
Quality of life; Chemoradiation; Neurocognitive Function; Low Grade Glioma
PubMed ID
43000083
Added to directory
Source checked

Report a correction or request removal